A rapid diagnostic test for Ebola has been developed by Swiss pharmaceutical group Roche and hopes to obtain fast-tract US approval for it. The company's director general declared this in an interview published Sunday, amid the worst-ever outbreak of the killer disease. The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use. Roche has filed for European Union approval of the test and plans ...
Read More
You have just read an article categorized health
titled Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test.
Written by:
editor -
Sunday, October 26, 2014
There are currently no comments for "Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test"
Post a Comment